(Q26827447)

Robert Udelsman

series ordinal

2

1 reference

language of work or name

1 reference

1 December 2014

1 reference

1 reference

120

1 reference

PubMed

issue

23

1 reference

PubMed

page(s)

3602-16

1 reference

Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Characteristics of patients surgically treated for primary hyperparathyroidism with and without renal stones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Therapeutic controversies in primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Outcome after surgery for primary hyperparathyroidism: ten-year prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Surgical approaches to primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Diagnosis and management of asymptomatic hyperparathyroidism: safety, efficacy, and deficiencies in our knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Psychiatric symptoms, bone density and non-specific symptoms in patients with mild hypercalcemia due to primary hyperparathyroidism: a systematic overview of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Sestamibi scans are not all created equally.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Factors contributing to negative parathyroid localization: an analysis of 1000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Parathyroid imaging: how good is it and how should it be done?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Parathyroid four-dimensional computed tomography: evaluation of radiation dose exposure during preoperative localization of parathyroid tumors in primary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

An optimal algorithm for intraoperative parathyroid hormone monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Cure predictability during parathyroidectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Intraoperative confirmation of parathyroid tissue during parathyroid exploration: a retrospective evaluation of the frozen section.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Mini-invasive video-assisted surgery of the thyroid and parathyroid glands: a 2011 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Endoscopic thyroidectomy and parathyroidectomy by the axillary approach. A preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Endoscopic thyroidectomy using a new bilateral axillo-breast approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Endoscopic thyroidectomy via a unilateral axillo-breast approach without gas insufflation for unilateral benign thyroid lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Postauricular and axillary approach endoscopic neck surgery: a new technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Robot assisted transaxillary surgery (RATS) for the removal of thyroid and parathyroid glands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Transoral thyroid and parathyroid surgery--development of a new transoral technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Robotic transaxillary endocrine surgery: a comparison with conventional open technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Anesthetic implications for robot-assisted transaxillary thyroid and parathyroid surgery: a report of twenty cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Who performs endocrine operations in the United States?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Avoidable reoperations for thyroid and parathyroid surgery: effect of hospital volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Conventional bilateral cervical exploration versus open minimally invasive parathyroidectomy under local anaesthesia for primary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Video-assisted versus conventional parathyroidectomy in primary hyperparathyroidism: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Remedial operation for primary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Approach to the patient with persistent or recurrent primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

High success rate of parathyroid reoperation may be achieved with improved localization diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Characterization of mutations in patients with multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Loss of heterozygosity in parathyroid glands of familial hypercalcemia with hypercalciuria and point mutation in calcium receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Recurrent renal hyperparathyroidism caused by parathyromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Parathyromatosis and parathyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Somatic and Germ-Line Mutations of theHRPT2Gene in Sporadic Parathyroid Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Parathyroid carcinoma: evaluation and interdisciplinary management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

25-Hydroxyvitamin D Status Does Not Affect Intraoperative Parathyroid Hormone Dynamics in Patients with Primary Hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Primary hyperparathyroidism detected in a health screening. The Trømsø study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

How asymptomatic is asymptomatic primary hyperparathyroidism?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Primary hyperparathyroidism: A prospective clinical study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Role of vitamin D deficiency in continued hyperparathyroidism following parathyroidectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

The effect of vitamin D levels on postoperative calcium requirements, symptomatic hypocalcemia, and parathormone levels following parathyroidectomy for primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Technetium-99m-sestamibi subtraction scintigraphy vs. ultrasonography combined with a rapid parathyroid hormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas and in directing surgical approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

A prospective evaluation of preoperative localization by technetium-99m sestamibi scintigraphy and ultrasonography in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasonography and computed tomography

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Pre-operative sestamibi-technetium subtraction scintigraphy in primary hyperparathyroidism: experience with 156 consecutive patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

5,000 parathyroid operations without frozen section or PTH assays: measuring individual parathyroid gland hormone production in real time

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Operative monitoring of parathyroid gland hyperfunction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Scandinavian Quality Register for Thyroid and Parathyroid Surgery: audit of surgery for primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Focused versus conventional parathyroidectomy for primary hyperparathyroidism: a prospective, randomized, blinded trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Operation for primary hyperparathyroidism: the new versus the old order. A randomised controlled trial of preoperative localisation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Clinical and histopathological characteristics of hyperparathyroidism-induced hypercalcemic crisis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Successful use of bisphosphonate and calcimimetic in neonatal severe primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Recurrent hyperparathyroidism secondary to parathyromatosis: clinical and imaging findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28891

7 January 2021

Identifiers

DOI

10.1002/CNCR.28891

1 reference

Consolidated OpenCitations Corpus – April 2017

4412831

4412831

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference